Chemed Corp at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone. Thank you for joining us this week at the JPMorgan Healthcare Conference. My name is Andrew Lang, and I'm an associate here on the JPMorgan health care team. It is my pleasure to introduce Kevin McNamara, President and CEO of Chemed; Nick Westfall, CEO of VITAS; and Mike Witzeman, CFO of Chemed.
With that, Kevin, I'll turn it over to you.
Thank you. Whenever I speak in with the group that is bigger than maybe [4 and 111], I always like to start with a little bit of history of Chemed because the question is bagged, what was the grand strategy between -- behind putting a hospice company together with a plumbing company? And so I'll just spend a couple of minutes talking about it. Chemed was a subsidiary of W.R. Grace & Company during the '70s.
At that point, it had a couple of specialty chemical companies and some health care companies. And it spun off the health care companies as Omnicare, a company now I guess part of CVS. And during the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |